backManaged care contracting legal risks have increased as a result of increasing drug prices, new efforts to develop more creative “value” arrangements, and increased focus on the pharmaceutical industry by the FTC. The legal risks often are not limited to one area of law (for example, just the anti-kickback statute).
This Webinar takes a inter-disciplinary approach to evaluating the legal risks associated with managed care contracting by pharmaceutical companies and provides practical advice regarding:
- Antitrust Laws
- Government Pricing Laws
- Fraud and Abuse Laws
You can also follow us on Twitter or Facebook.
Questions
If you have questions concerning this Roundtable Webinar, e-mail lifesciences-healthcare@kslaw.com.